0
Please log in or register to do it.

Alvogen Korea Zencigas Tablet

Alvogen Korea Zencigas Tablet

(Seoul = Larose.VIP) Reporter Cho Hyun-young = The Ministry of Food and Drug Safety has ruled out Kyung Kyung Pharmaceutical, a product with the same ingredients and content manufactured in the same factory as Alvogen Korea’s diabetes treatment drug ‘Genciga Gas Tablet’.[214390]It was announced on the 20th that the impurity ‘NTTP’ was detected in excess in ‘Zanustine Duo Tablet’ and Korea Hutex Pharmaceutical’s ‘Nanudang Si Home’ and a recall is in progress.

All three treatments are used as an adjunct to diet and exercise therapy to improve blood sugar control in type 2 diabetes patients, and are generic versions of Januvia, a treatment from global pharmaceutical company MSD. All three products are manufactured at Alvogen Korea’s second factory in Hwaseong.

NTTP is a nitrosamine-based compound and is known to be a carcinogen that can cause cancer in humans. The Ministry of Food and Drug Safety limits the allowable daily intake of NTTP to 37ng in this treatment.

The subjects of recall include Zencigas tablets with a manufacturing number of 23001 and an expiration date of June 21 of next year; Nanu Dangga products with a manufacturing number of 3001 and an expiration date of June 28 of next year; and Janustine Duo tablets with a manufacturing number of June 21 of next year. It is CC001 and the expiration date is June 28th of next year.

The Ministry of Food and Drug Safety requested drug dealers who possess the drug in question to stop using and selling the product and cooperate with the recall.

hyun0@yna.co.kr

Report to KakaoTalk okjebo 2024/02/20 10:23 Sent

[속보] Ministry of Health and Welfare: 6,415 residents at 100 hospitals resign... 1,630
Astronomy Research Institute releases music containing ‘Sounds of the Universe’ to commemorate 50th anniversary of founding

Reactions

0
0
0
0
0
0
Already reacted for this post.

Reactions

Your email address will not be published. Required fields are marked *